Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

360 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
To Treat or Not to Treat?
Levine SR, Weingast SZ, Weedon J, Stefanov DG, Katz P, Hurley D, Kasner SE, Khatri P, Broderick JP, Grotta JC, Feldmann E, Panagos PD, Romano JG, Bianchi R, Meyer BC, Scott PA, Kim D, Balucani C. Levine SR, et al. Stroke. 2018 Aug;49(8):1933-1938. doi: 10.1161/STROKEAHA.118.020971. Stroke. 2018. PMID: 29976582
Factors associated with early presentation of acute stroke.
Feldmann E, Gordon N, Brooks JM, Brass LM, Fayad PB, Sawaya KL, Nazareno F, Levine SR. Feldmann E, et al. Among authors: levine sr. Stroke. 1993 Dec;24(12):1805-10. doi: 10.1161/01.str.24.12.1805. Stroke. 1993. PMID: 8248959
Intravenous thrombolysis for acute stroke.
Lyden PD, Grotta JC, Levine SR, Marler JR, Frankel MR, Brott TG. Lyden PD, et al. Among authors: levine sr. Neurology. 1997 Jul;49(1):14-20. doi: 10.1212/wnl.49.1.14. Neurology. 1997. PMID: 9222164 Review. No abstract available.
Effects of tissue plasminogen activator for acute ischemic stroke at one year. National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study Group.
Kwiatkowski TG, Libman RB, Frankel M, Tilley BC, Morgenstern LB, Lu M, Broderick JP, Lewandowski CA, Marler JR, Levine SR, Brott T. Kwiatkowski TG, et al. Among authors: levine sr. N Engl J Med. 1999 Jun 10;340(23):1781-7. doi: 10.1056/NEJM199906103402302. N Engl J Med. 1999. PMID: 10362821 Free article. Clinical Trial.
Initial clinical experience with IV tissue plasminogen activator for acute ischemic stroke: a multicenter survey. The t-PA Stroke Survey Group.
Tanne D, Bates VE, Verro P, Kasner SE, Binder JR, Patel SC, Mansbach HH, Daley S, Schultz LR, Karanjia PN, Scott P, Dayno JM, Vereczkey-Porter K, Benesch C, Book D, Coplin WM, Dulli D, Levine SR. Tanne D, et al. Among authors: levine sr. Neurology. 1999 Jul 22;53(2):424-7. doi: 10.1212/wnl.53.2.424. Neurology. 1999. PMID: 10430444 Clinical Trial.
Agreement and variability in the interpretation of early CT changes in stroke patients qualifying for intravenous rtPA therapy.
Grotta JC, Chiu D, Lu M, Patel S, Levine SR, Tilley BC, Brott TG, Haley EC Jr, Lyden PD, Kothari R, Frankel M, Lewandowski CA, Libman R, Kwiatkowski T, Broderick JP, Marler JR, Corrigan J, Huff S, Mitsias P, Talati S, Tanne D. Grotta JC, et al. Among authors: levine sr. Stroke. 1999 Aug;30(8):1528-33. doi: 10.1161/01.str.30.8.1528. Stroke. 1999. PMID: 10436095 Clinical Trial.
Early stroke treatment associated with better outcome: the NINDS rt-PA stroke study.
Marler JR, Tilley BC, Lu M, Brott TG, Lyden PC, Grotta JC, Broderick JP, Levine SR, Frankel MP, Horowitz SH, Haley EC Jr, Lewandowski CA, Kwiatkowski TP. Marler JR, et al. Among authors: levine sr. Neurology. 2000 Dec 12;55(11):1649-55. doi: 10.1212/wnl.55.11.1649. Neurology. 2000. PMID: 11113218 Clinical Trial.
360 results